Phase 1 Chronic Rhinosinusitis (CRS) Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray
Chronic Rhinosinusitis (CRS)
VivaVision Biotech, Inc60 enrolled1 locationNCT07259538
Recruiting
Phase 1Phase 2
Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial
Chronic Rhinosinusitis (CRS)
St. Paul's Hospital, Canada100 enrolled1 locationNCT06750302